Payers, Providers Want More Data From Biopharma Companies

Two PhRMA-funded surveys found that payers and providers would like more information from biopharmaceutical companies about approved and unapproved uses of medicines, including products undergoing clinical trials.

The surveys, conducted by Health Strategies Group, questioned 38 payer executives from integrated delivery networks, managed care organizations and pharmacy benefit managers, as well as 178 physicians from a range of specializations.

Survey participants were asked about their use of information across the drug lifecycle and questioned about their interest in products in clinical trials pending FDA review, FDA approved products and unapproved usages of approved medicines.